High transplant-related mortality associated with haematopoietic stem cell transplantation for paediatric therapy-related acute myeloid leukaemia (t-AML). A study on behalf of the United Kingdom Paediatric Blood and Bone Marrow Transplant Group

被引:7
|
作者
Gassas, Adam [1 ]
Sivaprakasam, Ponni [1 ]
Cummins, Michelle [1 ]
Breslin, Patricia [1 ]
Patrick, Katharine [2 ]
Slatter, Mary [3 ]
Skinner, Roderick [3 ]
Shenton, Geof [3 ]
Gibson, Brenda [4 ]
Lawson, Sarah [5 ]
Petterson, Toni [6 ]
Potter, Michael [6 ]
James, Beki [7 ]
Hough, Rachael [8 ]
Hiwarkar, Prashant [9 ]
Vora, Ajay [10 ]
Veys, Paul [10 ]
De la Fuente, Josu [11 ]
Wynn, Robert [9 ]
Amrolia, Persis [10 ]
机构
[1] Royal Hosp Children, Dept Haematol & Oncol, Bristol, Avon, England
[2] Sheffield Childrens Hosp, Dept Haematol & Oncol, Sheffield, S Yorkshire, England
[3] Great North Childrens Hosp, Childrens Haemopoiet Stem Cell Transplant Unit, Newcastle Upon Tyne, Tyne & Wear, England
[4] Royal Hosp Children, Dept Haematol & Oncol, Glasgow, Lanark, Scotland
[5] Birmingham Childrens Hosp, Dept Haematol & Oncol, Birmingham, W Midlands, England
[6] Royal Marsden Hosp, Dept Haematol & Oncol, Sutton, Surrey, England
[7] Leeds Teaching Hosp, Dept Haematol & Oncol, Leeds, W Yorkshire, England
[8] UCL, Dept Haematol & Oncol, London, England
[9] Royal Manchester Childrens Hosp, Dept Haematol & Oncol, Manchester, Lancs, England
[10] Great Ormond St Hosp Sick Children, Dept Haematol & Oncol, London, England
[11] Imperial Coll, St Marys Hosp, Dept Haematol & Oncol, London, England
关键词
MYELODYSPLASTIC SYNDROME; SECONDARY; CHILDREN; FLUDARABINE; BUSULFAN; AML;
D O I
10.1038/s41409-018-0157-x
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Paediatric therapy-related acute myeloid leukaemia (t-AML) is rare and the outcome is poor. While allogeneic haematopoietic stem cell transplantation (HSCT) is generally the accepted modality of treatment, data regarding salvage chemotherapy, remission induction, conditioning regimens, transplant-related mortality and outcome is scarce. Between 2000 and2016, 36 children with t-AML were treated in seven UK paediatric HSCT centres. The most common salvage protocol for remission induction was FLAG with or without idarubicin and 28 patients were in complete morphological remission prior to BMT. Only 12 patients survived (33%). Transplant-related mortality (TRM) was the leading cause of death.
引用
收藏
页码:1165 / 1169
页数:5
相关论文
共 27 条
  • [21] Allogeneic stem cell transplantation for patients with acute myeloid leukemia (AML) in second complete remission (CR2) transplanted from unrelated donors with post-transplant cyclophosphamide (PTCy). A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
    Arnon Nagler
    Myriam Labopin
    Ryszard Swoboda
    Alexander Kulagin
    Hélène Labussière-Wallet
    Montserrat Rovira
    Didier Blaise
    Jan Vydra
    Ibrahim Yakoub-Agha
    Goda Choi
    Péter Reményi
    Yener Koc
    Jaime Sanz
    Fabio Ciceri
    Mohamad Mohty
    Bone Marrow Transplantation, 2023, 58 : 552 - 557
  • [22] Low relapse without excessive transplant-related mortality following allogeneic stem cell transplantation in patients with high-risk secondary acute myeloblastic leukaemia and myelodysplastic syndromes: long-term outcomes in a single-centre experience
    Castagna, L.
    Furst, S.
    Faucher, C.
    Charbonnier, A.
    Vey, N.
    Blaise, D.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S92 - S93
  • [23] IMPACT OF CYTOGENETIC ABNORMALITIES ON OUTCOME AFTER ALLOGENEIC STEM CELL TRANSPLANTATION FOR THERAPY-RELATED MYELODYSPLASTIC SYNDROME (T-MDS) AND ACUTE MYELOID LEUKEMIA. A REPORT FROM THE MDS SUBCOMMITTEE OF THE CHRONIC LEUKEMIA WORKING PARTY OF THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATI
    Kroeger, N.
    Brand, R.
    Van Biezen, A.
    Zander, A.
    Dierlamm, J.
    Niederwieser, D.
    Devergie, A.
    Trapani, R.
    Cornish, J.
    Van der Borne, P.
    Ljungman, P.
    Gratwohl, A.
    Cordonnier, C.
    Beelen, D.
    Deconinck, E.
    Symoneidis, A.
    De Witte, T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 361 - 362
  • [24] Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT) for Standard and High Risk Acute Lymphoblastic Leukemia (ALL) Patients Using Irradiation-Free Conditioning Regimen is Associated with Lower Incidence of Transplant Related Mortality
    Fathy, Gamal M.
    Mahmoud, Hossam K.
    El-Haddad, Alaa
    Fahmy, Omar
    Abdelfattah, Raafat
    Abdel-Mooti, Mohamed
    Bokhary, Mahmoud
    Ibrahim, Shaimaa
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S181 - S181
  • [25] Allogeneic Bone Marrow Transplants for Pediatric Severe Aplastic Anemia: Real-world Data comparing Matched Related and Unrelated Donors in a Developing Country. Retrospective study on behalf of the Pediatric Hematopoietic Stem Cell Transplant Working Group of the Brazilian Bone Marrow Transplantation Society (SBTMO) and the Brazil-Seattle Consortium (Gedeco)
    Darrigo, Luiz Guilherme, Jr.
    Colturato, Vergilio
    de Souza, Mair Pedro
    Loth, Gisele
    Calixto, Rodolfo
    Seber, Adriana
    Zecchin, Victor Gottardello
    Daudt, Liane Esteves
    Tavares, Barbosa
    Arcuri, Leonardo
    de Macedo, Antonio Vaz
    Vieira, Ana Karine
    Kuwahara, Cilmara
    Ribeiro, Lisandro
    Fernandes, Juliana Folloni
    Flowers, Mary E.
    Pasquini, Ricardo
    Bonfim, Carmem
    PEDIATRIC TRANSPLANTATION, 2019, 23 (07)
  • [26] Results of a Phase III Randomized, Multi-Center Study of Allogeneic Stem Cell Transplantation after High Versus Reduced Intensity Conditioning in Patients with Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML): Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0901
    Scott, Bart L.
    Pasquini, Marcelo C.
    Logan, Brent
    Wu, Juan
    Devine, Steve
    Porter, David L.
    Maziarz, Richard T.
    Warlick, Erica
    Fernandez, Hugo F.
    Alyea, Edwin P.
    Hamadani, Mehdi
    Bashey, Asad
    Giralt, Sergio A.
    Leifer, Eric
    Geller, Nancy
    Le-Rademacher, Jennifer
    Mendizabal, Adam M.
    Horowitz, Mary M.
    Deeg, H. Joachim
    Horwitz, Mitchell E.
    BLOOD, 2015, 126 (23)
  • [27] Response to Rituximab-Based Therapy and Risk Factor Analysis in Epstein Barr Virus-Related Lymphoproliferative Disorder After Hematopoietic Stem Cell Transplant in Children and Adults: A Study From the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
    Styczynski, Jan
    Gil, Lidia
    Tridello, Gloria
    Ljungman, Per
    Donnelly, Peter
    van der Velden, Walter
    Omar, Hamdy
    Martino, Rodrigo
    Halkes, Constantijn
    Faraci, Maura
    Theunissen, Koen
    Kalwak, Krzysztof
    Hubacek, Petr
    Sica, Simona
    Nozzoli, Chiara
    Fagioli, Franca
    Matthes, Susanne
    Diaz, Miguel A.
    Migliavacca, Maddalena
    Balduzzi, Adriana
    Tomaszewska, Agnieszka
    de la Camara, Rafael
    van Biezen, Anja
    Hoek, Jennifer
    Iacobelli, Simona
    Einsele, Hermann
    Cesaro, Simone
    CLINICAL INFECTIOUS DISEASES, 2013, 57 (06) : 794 - 802